Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Weiman Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of high-end generic drugs and innovative small molecule therapeutics. The company focuses on complex formulations and difficult-to-synthesize active pharmaceutical ingredients (APIs) across therapeutic areas such as cardiovascular health, metabolic diseases, and the central nervous system. Operating out of Hefei, Anhui, the firm maintains state-of-the-art GMP-compliant facilities to support its internal pipeline and provide contract manufacturing services. Weiman Pharmaceutical aims to improve global access to affordable, high-quality medicine through advanced chemical synthesis and formulation technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Weiman Pharmaceutical.